Metabolomic Discoveries - DE

“Local sales representative to identify new potential partners“

Remembrane SrL – from Italy

“Patience is a key word when dealing with Japan“

About the Report 

This report presents an overview of the Biotechnology market in Japan. After giving a comprehensive definition of biotechnology, this report focuses on the characteristics of this market by providing information on its size and structure. Furthermore it includes information concerning biotech regulation in Japan as well as a complete list of major players and their specificities on the Japanese market. Lastly, this report provides various recommendations to EU companies for a successful market entry.

Sphere Fluidics – from the UK

Which opportunities does the Biopharmaceutical market in Japan offer to EU companies?

About the Report 

This report is an updated edition of a first study on cell technology, cell therapy, tissue engineering and gene therapy in Japan published in 2015. It aims to summarise key events which have taken place in academic and medical research in these different fields. Furthermore, the report includes information concerning Japanese industrial landscapes as well as Japanese Government activities related to these medical advances. Lastly, it provides various recommendations to EU companies for a successful market entry.

Only a few weeks left to apply for the next Biotech training mission in Japan!

You are an EU SME/Cluster operating in Biotech sectors; you want to identify key contacts for business collaborations in Japan;

Programme dates: 10 - 13 October 2017
Deadline: Wednesday, 31 May 2017 

OcellO – from NL

OcellO B.V. was founded in 2011 in Leiden. It is a privately owned contract research organisation based on technology developed at Leiden University. 

Protobios – from EE    

Protobios Ltd. was founded in 2003. The company is developing new diagnostic tests and offering services in the field of immunology analysis. Since their founding the company has contributed to the development of novel technologies in field cell technology and immunology.

About the Report: